| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |